Gilead CFO Andrew Dickinson Sells 3,000 Shares

What Happened
Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences (GILD), reported the sale of 3,000 shares on 2026-09-15 at $145.29 per share, generating gross proceeds of $435,870. The sale is reported as an open-market or private sale (code S).

Key Details

• Transaction date: 2026-09-15; filing date: 2026-09-16 (filed the next day).
• Price: $145.29 per share; total proceeds: $435,870.
• Shares owned after transaction: not specified in the provided filing summary.
• Footnote: The sale was made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024 (pre-arranged trading plan).
• Transaction type: Sale (S).

Context
Sales executed under a 10b5-1 plan are typically pre-arranged and scheduled in advance, which can make them less indicative of an insider’s current view of the company. This report appears to have been filed promptly (next day). As always, retail investors should consider insider activity alongside broader fundamentals and market context.